Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
MediciNova, Inc. (NASDAQ: MNOV)
MNOV Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
152.60%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
373.50%
MNOV Stock Analysis
MNOV
PE Ratio:
MNOV
PEG Ratio:
Not Available
MNOV
Forward EPS Growth (12 month):
0.00%
MNOV
PS Ratio:
108.9
MNOV
PSG Ratio:
0.5
MNOV
Forward Revenue Growth (12 month):
220.00%
MNOV Articles
No data was found